Axim Biotechnologies

Axim Biotechnologies P/B

The P/B (Price-to-Book Ratio) of Axim Biotechnologies (AXIM) as of Nov 5, 2026 is -0.37. In the previous year, P/B (Price-to-Book Ratio) was -0.41 — a change of -8.32% (higher).

P/B

-0.37

YoY

-8.32%

Last updated:

P/B (Price-to-Book Ratio) of Axim Biotechnologies is 2025 -0.37 . P/B (Price-to-Book Ratio) of Axim Biotechnologies was 2024 -0.41 . It decreases by -8.32% higher compared to the previous year.

The Axim Biotechnologies P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
-0.70 USD
Jan 1, 2019
-0.63 USD
Jan 1, 2020
2.71 USD
Jan 1, 2021
-1.82 USD
Jan 1, 2022
-0.88 USD
Jan 1, 2023
-0.55 USD
Jan 1, 2024
-0.41 USD
Jan 1, 2025
-0.37 USD
The Axim Biotechnologies P/B history
YEARP/BYoY
-0.37-8.32%
-0.41-26.52%
-0.55-36.98%
-0.88-51.54%
-1.82-166.97%
2.71-531.75%
-0.63-10.04%
-0.70+3.33%
-0.68-62.26%
-1.79-28.52%
-2.50-65.74%
-7.31—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axim Biotechnologies Stock analysis

What does Axim Biotechnologies do? Axim Biotechnologies Inc is an innovative biotechnology company focusing on the research, development, and marketing of pharmaceutical products, medical devices, and diagnostic tests based on cannabis. The company is headquartered in New York City and has become one of the leading companies in the industry since its founding in 2014. Axim Biotechnologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axim Biotechnologies stock

P/B (Price-to-Book Ratio) of Axim Biotechnologies is -0.37 in 2025.

P/B (Price-to-Book Ratio) of Axim Biotechnologies changed from -0.41 to -0.37, representing a -8.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Axim Biotechnologies since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Axim Biotechnologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Axim Biotechnologies

All Key Metrics — Axim Biotechnologies